Page last updated: 2024-11-05

rhodium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Rhodium is a hard, silvery-white, corrosion-resistant transition metal. It is a member of the platinum group and is found in nature as a trace element in sulfide ores. Rhodium is obtained as a byproduct of nickel and copper mining. Rhodium is highly valued for its catalytic properties, and it is used in a variety of applications, including automotive catalytic converters, chemical synthesis, and the production of optical fibers. Rhodium is also used in jewelry and other decorative items. Rhodium is a relatively rare metal, and its price is highly volatile. The demand for rhodium is driven by the growth of the automotive industry and the development of new catalytic applications. Rhodium is an important metal for a variety of industries, and it is likely to continue to be in high demand in the future.'

Rhodium: A hard and rare metal of the platinum group, atomic number 45, atomic weight 102.905, symbol Rh. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

rhodium atom : A cobalt group element atom of atomic number 45. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID23948
CHEBI ID33359
MeSH IDM0019042

Synonyms (127)

Synonym
rhodium, elemental
einecs 231-125-0
hsdb 2534
rhodium fume
rhodium, metal
rhodium black
rodio
rhodium atom
7440-16-6
rhodium
CHEBI:33359 ,
45rh
RH ,
rhodium on carbon, extent of labeling: 5 wt. % dry loading, matrix carbon, wet support, degussa type g106b/w, reduced
rhodium on alumina, extent of labeling: 5 wt. % loading, degussa type g214 ra/d
rhodium, wire, diam. 1.0 mm, 99.9% trace metals basis
rhodium, powder, 99.95% trace metals basis
rhodium, sponge, 99.9% trace metals basis
rhodium on alumina, extent of labeling: 5 wt. % loading, matrix alumina support, powder
rhodium, foil, thickness 0.025 mm, 99.9% trace metals basis
rhodium on carbon, extent of labeling: 5 wt. % loading
rhodium on alumina, extent of labeling: 0.5 wt. % loading, pellets, 3.2 mm
rhodium-103
R0075
rhodium(2+)
A838113
rhodium (i)
OBDSITLACDGNMC-UHFFFAOYSA-N
hsdb 7121
R024050000 ,
unii-dmk383dsac
dmk383dsac ,
BP-13287
FT-0618358
FT-0615667
FT-0619649
rhodium metallicum [hpus]
rhodium [hsdb]
rhodium metallicum
rhodium [mi]
EPITOPE ID:131798
AKOS015900768
rhodium on carbon
rhodium on alumina
rh/al2o3
MHOVAHRLVXNVSD-UHFFFAOYSA-N
rh/c
rhodium-on-alumina
rhodium/alumina
rhodium/carbon
rhodium-on-carbon
rh on carbon
rh on alumina
DTXSID3052480
rhodium powder, -60 mesh
FT-0698918
rhodium wire, 0.5mm (0.02in) dia
rhodium 5% on carbon (wetted with ca. 55% water)
rhodium wire, 0.25mm (0.01in) dia
rhodium wire, 1.0mm (0.04in) dia
rhodium, 1% on alumina powder, reduced
rhodium, 5% on carbon, dry
mfcd00011201
mfcd03458392
rhodium, 5% on carbon
rhodium powder
rhodium, 5% on alumina
rhodium icp-ms standard, ready-to-use, 10 mg/kg rh in nitric acid
rhodium, foil, 12mm disks, thickness 1.0mm, as rolled, 99.9%
rhodium, microfoil, disks, 10mm, thinness 0.25mum, specific density 310mug/cm2, permanent mylar 3.5mum support, 99.99%
rhodium, foil, light tested, 25x25mm, thickness 0.075mm, as rolled, 99.9%
rhodium, wire reel, 0.1m, diameter 0.25mm, hard, 99.9%
rhodium, foil, 25x25mm, thickness 0.1mm, as rolled, 99.9%
rhodium, foil, light tested, 25x25mm, thickness 0.025mm, as rolled, x-ray quality, 99.9%
rhodium, microfoil, disks, 10mm, thinness 0.1mum, specific density 124mug/cm2, permanent mylar 3.5mum support, 99.9%
rhodium, foil, not light tested, 10x10mm, thickness 0.012mm, as rolled, 99.9%
rhodium, microfoil, disks, 25mm, thinness 0.1mum, specific density 124mug/cm2, permanent mylar 3.5mum support, 99.9%
rhodium, foil, 12mm disks, thickness 0.5mm, as rolled, 99.9%
rhodium, wire reel, 0.05m, diameter 0.12mm, as drawn, 99.9%
rhodium, foil, not light tested, 25x25mm, thickness 0.006mm, as rolled, 99.9%
rhodium, wire reel, 0.2m, diameter 0.25mm, hard, 99.9%
rhodium, wire reel, 0.1m, diameter 0.5mm, as drawn, 99.9%
rhodium, foil, not light tested, 50x50mm, thickness 0.006mm, as rolled, 99.9%
rhodium, foil, light tested, 15x15mm, thickness 0.05mm, as rolled, 99.9%
rhodium, wire reel, 0.5m, diameter 0.25mm, hard, 99.9%
rhodium, wire reel, 0.05m, diameter 1.0mm, as drawn, 99.9%
rhodium, foil, thickness 0.025 mm, size 10 x 10 mm, purity 99.9%
rhodium, foil, thickness 0.025 mm, size 25 x 25 mm, purity 99.9%
rhodium, wire reel, 0.05m, diameter 0.25mm, hard, 99.9%
rhodium, microfoil, disks, 10mm, thinness 0.50mum, specific density 620mug/cm2, permanent mylar 3.5mum support, 99.99%
rhodium, wire reel, 0.05m, diameter 0.5mm, as drawn, 99.9%
rhodium, wire reel, 0.2m, diameter 0.12mm, as drawn, 99.9%
rhodium, foil, light tested, 25x25mm, thickness 0.05mm, as rolled, 99.9%
rhodium, foil, 25x25mm, thickness 0.125mm, as rolled, 99.9%
rhodium, foil, light tested, 25x25mm, thickness 0.05mm, as rolled, x-ray quality, 99.9%
rhodium, wire reel, 0.1m, diameter 1.0mm, as drawn, 99.9%
rhodium, wire reel, 0.1m, diameter 0.12mm, as drawn, 99.9%
rhodium, foil, 25x25mm, thickness 0.15mm, as rolled, 99.9%
rhodium, wire, 1.0 mm diameter, length 0.025 m, purity 99.9%
rhodium, microfoil, disks, 25mm, thinness 0.25mum, specific density 310mug/cm2, permanent mylar 3.5mum support, 99.99%
rhodium, wire reel, 0.5m, diameter 0.12mm, as drawn, 99.9%
rhodium, foil, not light tested, 25x25mm, thickness 0.012mm, as rolled, 99.9%
rhodium, wire reel, 0.2m, diameter 0.5mm, as drawn, 99.9%
rhodium, 5% on alumina powder, reduced
hydridorhodium
rhodium hydride
rhodium atomic absorption standard
rhodium single crystal disc, 10mm (0.4in) dia., 1-2mm (0.04-0.08in) thick, (111) orientation, +/-0.5 degrees
Q1087
rhodium 5% on carbon, 50%-70% water
rhodium nanorods
rhodium metal powder
rhodium nanofoil
lead oxide (pbo) sputtering targets
rhodium on carbon extent of labeling: 5 wt. % loading 50% wetted with water
rhodium on carbon extent of labeling: 5 wt. % loading
rhodium (5per cent on alumina)
SY003717
rhodium, powder
AT32573
rhodium on alumina, 5% rh
rhodium - rh @ 10 microg/ml in 2% hcl
rhodium internal standard: rh @ 10 microg/ml in 2% hcl
rhodium standard: rh @ 1000 microg/ml in 20% hcl
rhodium standard: rh @ 10 microg/ml in 2% hcl
rhodium(ii) ion
rhodium - rh @ 1000 microg/ml in 20% hcl

Research Excerpts

Overview

Rhodium is a non-toxic transition metal used as various nanomaterials with unique structures and properties. The rhodium catalyst serves as a chiral Lewis acid to activate the 2-acyl imidazole dienophile by two-point binding.

ExcerptReferenceRelevance
"Rhodium (Rh) is a non-toxic transition metal used as various nanomaterials with unique structures and properties. "( Rhodium-Based Nanozymes: Recent Advances and Challenges.
Chen, C; Dai, P; Li, J; Sun, T, 2023
)
3.8
"The rhodium catalyst serves as a chiral Lewis acid to activate the 2-acyl imidazole dienophile by two-point binding and overrules the preferred regioselectivity of the uncatalyzed reaction."( Asymmetric Synthesis of Hydrocarbazoles Catalyzed by an Octahedral Chiral-at-Rhodium Lewis Acid.
Gong, L; Huang, Y; Meggers, E; Song, L, 2015
)
1.13

Effects

Dirhodium(II) catalysts have been widely used as a remarkable tool in organic synthesis. A rhodium/binap complex has been found to effectively catalyze the isomerization of unactivated internal alkynes to the corresponding 1,3-dienes.

ExcerptReferenceRelevance
"Dirhodium(II) catalysts have been widely used as a remarkable tool in organic synthesis, ultimately resulting in a myriad of transformations and formation of a wide variety of compounds, every so often intermediaries in drug synthesis. "( Making expensive dirhodium(II) catalysts cheaper: Rh(II) recycling methods.
Afonso, CA; Candeias, NR; Gois, PM, 2012
)
1.43
"A rhodium/binap complex has been found to effectively catalyze the isomerization of unactivated internal alkynes to the corresponding 1,3-dienes in the presence of an azomethine imine as the reaction promoter."( Rhodium-catalyzed isomerization of unactivated alkynes to 1,3-dienes.
Duan, WL; Hayashi, T; Park, S; Shintani, R, 2006
)
2.5
"Rhodium(II) acetate has been shown to have carcinostatic activity in Swiss mice bearing Ehrlich ascites tumors. "( The metabolism of rhodium(II) acetate in tumor-bearing mice.
Bear, JL; Erck, A; Kimball, AP; Sherwood, E, 1976
)
2.03

Actions

Rhodium did not increase the signs of nickel deficiency. Platinum catalysts produce mainly autothermal non-equilibrium products.

ExcerptReferenceRelevance
"Rhodium catalysts produce equilibrium selectivity to syngas, while platinum catalysts produce mainly autothermal non-equilibrium products."( Autothermal catalytic partial oxidation of glycerol to syngas and to non-equilibrium products.
Kruger, JS; Rennard, DC; Schmidt, LD, 2009
)
1.07
"Rhodium did not increase the signs of nickel deficiency."( Nickel deficiency and nickel-rhodium interaction in chicks.
Givand, SH; Myron, DR; Nielsen, FH; Ollerich, DA, 1975
)
1.27

Treatment

ExcerptReferenceRelevance
"The treatment with rhodium (II) citrate-loaded maghemite nanoparticles and magnetoliposomes induced more specific cytotoxicity on breast carcinoma cells than on breast normal cells, which is the opposite of the results observed with free Rh(2)(H(2)cit)(4) treatment. "( Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy.
Báo, SN; Carneiro, ML; da Silva, IC; de Souza, AR; Lacava, ZG; Lourenço, LH; Nunes, ES; Oliveira, RG; Peixoto, RC; Simioni, AR; Tedesco, AC, 2011
)
1.21

Bioavailability

ExcerptReferenceRelevance
" Because of analytical problems in detecting Pd in small biological samples the present investigation concentrates on the bioavailability of this metal."( First report on the uptake of automobile catalyst emitted palladium by European eels (Anguilla anguilla) following experimental exposure to road dust.
Alt, F; Messerschmidt, J; Sures, B; von Bohlen, A; Zimmermann, S, 2001
)
0.31
" This significant heavy metal accumulation by acanthocephalans, even surpassing that of established free living accumulation bioindicators, encouraged us to study the bioavailability of the platinum-group-metals (PGM) Pt and Rh for parasites."( The acanthocephalan Paratenuisentis ambiguus as a sensitive indicator of the precious metals Pt and Rh from automobile catalytic converters.
Sonntag, C; Stüben, D; Sures, B; Taraschewski, H; Zimmermann, S, 2003
)
0.32
" This review summarises current knowledge concerning the environmental mobility, speciation and bioavailability of Pt, Pd and Rh."( Environmental routes for platinum group elements to biological materials--a review.
Ek, KH; Morrison, GM; Rauch, S, 2004
)
0.32
" Organic ligands found in soils have the potential to increase the mobility of PGEs and potentially increase the bioavailability of the metals."( Potential mobilization of platinum-group elements by siderophores in surface environments.
Dahlheimer, SR; Fein, JB; Neal, CR, 2007
)
0.34
" Pt showed the highest absolute bioavailability however, due to its greater concentration in environmental samples."( The estimation of the bioavailabilities of platinum, palladium and rhodium in vehicle exhaust catalysts and road dusts using a physiologically based extraction test.
Colombo, C; Monhemius, AJ; Plant, JA, 2008
)
0.58
" More recent studies on PGE toxicity, environmental bioavailability and concentrations in biologically relevant media indicate however that environmental exposures to these metals may indeed pose a health risk, especially at a chronic, subclinical level."( Airborne particulate matter, platinum group elements and human health: a review of recent evidence.
Wiseman, CL; Zereini, F, 2009
)
0.35
" Access to this methodology has permitted the construction of two new adenylated sulfoximines, which were expected to exhibit similar binding affinity and better bioavailability than the original human ASNS inhibitor."( A critical electrostatic interaction mediates inhibitor recognition by human asparagine synthetase.
Ding, Y; Hiratake, J; Ikeuchi, H; Meyer, ME; Richards, NG, 2009
)
0.35
" Despite the bioavailability of these metals to plants and animals, studies determining the effects of PGE on organisms are extremely rare."( Impact of platinum group elements on the soil invertebrate Enchytraeus crypticus.
Bednarova, I; Beklova, M; Havelkova, B; Kovacova, V; Pikula, J, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
" Because of the rapid fall-off radiation dose it is possible to deliver a high dosage to the tumor without danger of radiogenic damage to the whole globe."( beta-Irradiation of retinoblastoma with 106Ru/106Rh applicators.
Lommatzsch, P, 1977
)
0.26
" Beyond the threshold dose, the degree of potentiation for all complexes in PBS approximated 12 times the degree of radiation sensitivity seen for the N2 baseline of the radiation dose-response curve."( Potentiation of radiation-induced bacterial cell killing by binuclear rhodium(II) carboxylates.
Farrell, NP; Mahtani, HK; Richmond, RC, 1989
)
0.51
" No dose-response relationship could be established from the ophthalmological, morphological and functional findings."( Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru/106Rh plaques.
Alberti, W; Lommatzsch, PK; Lommatzsch, R; Rohrwacher, F, 1994
)
0.29
" The five most active salts were selected: [Rh(III)(2-amino-6-ethoxybenzothiazole)(4)Br(2)](+)Br(-); [Rh(III)(2-bromothiazole)(4)(Br)(2)](+)Br(-); [Rh(III)(mefloquine)(4)(Cl)(2)](+)Cl(-); [Rh(III)(2-mepacrine)(4)(Cl)(2)](+)Cl(-), and [Rh(III)(oxamniquine)(4)(Cl)(2)](+)Cl(-), which induced growth-inhibition rates of more than 50% at 24 h of treatment and at the maximum dosage tested."( In vitro and in vivo activity of new rhodium (III) complexes against Leishmania donovani.
Azzouz, S; Craciunescu, D; De Frutos, MI; Gutierrez-Rios, MT; Mesa-Valle, CM; Moraleda-Lindez, V; Osuna, A; Rodriguez-Cabezas, MN, 2001
)
0.58
" Compared with 125I plaques a bi-nuclide plaque allows to maintain the tumor dosage while the dose in the irradiated volume outside of the target volume is significantly reduced."( The design and the dosimetry of bi-nuclide radioactive ophthalmic applicators.
Anastassiou, G; Bornfeld, N; Flühs, D; Sauerwein, W; Wening, J, 2004
)
0.32
" The dose-response curves obtained by exposure (2 h) to the metals (nanogram per gram range) suggested the same mechanisms of action, with Rh showing the greatest curve steepness and the lowest EC50 value."( Functional toxicity and tolerance patterns of bioavailable Pd(II), Pt(II), and Rh(III) on suspended Saccharomyces cerevisiae cells assayed in tandem by a respirometric biosensor.
Campanella, L; Dragone, R; Frazzoli, C; Mantovani, A; Massimi, C, 2007
)
0.34
" For example, we could determine that the frequently observed three protrusions within the pore appearing in STM images obtained after dosing small amounts of water, are most likely determined by water hexamers."( Investigation of h-BN/Rh(111) nanomesh interacting with water and atomic hydrogen.
Ding, Y; Hutter, J; Iannuzzi, M, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
cobalt group element atom
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (3,206)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990170 (5.30)18.7374
1990's107 (3.34)18.2507
2000's1014 (31.63)29.6817
2010's1603 (50.00)24.3611
2020's312 (9.73)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 100.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index100.87 (24.57)
Research Supply Index8.09 (2.92)
Research Growth Index5.35 (4.65)
Search Engine Demand Index194.24 (26.88)
Search Engine Supply Index2.09 (0.95)

This Compound (100.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.03%)5.53%
Reviews93 (2.86%)6.00%
Case Studies11 (0.34%)4.05%
Observational0 (0.00%)0.25%
Other3,150 (96.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]